Saturday April 10, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions
  • 2021 Archive
  • 2020 Archive
  • 2019 Archive
  • 2018 Archive
  • 2017 Archive
  • 2016 Archive
  • 2015 Archive
  • 2014 Archive
  • 2013 Archive
  • 2012 Archive
  • 2011 Archive
  • 2010 Archive
  • 2009 Archive
  • 2008 Archive
  • 2007 Archive
  • 2006 Archive
  • 2005 Archive
  • 2004 Archive
  • 2003 Archive

Issue Archive




Jan 2003 
Vol. 1, No. 1



Feb 2003 
Vol. 1, No. 2



Mar 2003 
Vol. 1, No. 3
 



Apr 2003 
Vol. 1, No. 4



May 2003 
Vol. 1, No. 5



Jun 2003 
Vol. 1, No. 6
 



Jul 2003 
Vol. 1, No. 7



Aug 2003 
Vol. 1, No. 8



Sep 2003 
Vol. 1, No. 9
 



Sep 2003 Supplement
Vol. 1, No. 1



Oct 2003 
Vol. 1, No. 10



Nov 2003 
Vol. 1, No. 11
 



Dec 2003 
Vol. 1, No. 12
 

Editor’s Choice

  • BioProcess Insider

    BARDA to give Emergent another $23m for tech after J&J jab mix-up

  • BioProcess Insider

    Sanofi to build $700m Canadian flu vaccine plant

  • Sponsored Content

    Bursting the bubble: COVID-19 and the gene therapy skills base

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

  • BioProcess Insider

    Catalent increases capacity in Italy for J&J’s COVID vaccine

  • Sponsored Content

    Increase Efficiency in Your Manufacturing With the Right Buffer Management Strategy

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 3 weeks ago
  • Tweet Avatar RT @Dan5tanton: Thermo Fisher’s $600 million CAPEX has got the trade press salivating. But similar statements, expansions underway,… https://t.co/5xHNdfJwRw 4 weeks ago
  • Tweet Avatar RT @Dan5tanton: Calls for standardization to boost manufacturing agility by executives from Novavax, Fujifilm, and Biocon after a C… https://t.co/UJO2CH09K8 1 month ago
  • Tweet Avatar VIVEbiotech has responded to the high demand for lentiviral vectors in the cell and gene therapy space by expanding… https://t.co/y11zPEBs0E 1 month ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    ‘mRNA has been validated’ – Pfizer looks beyond COVID

  • BioProcess Insider

    Lonza dedicates suite to make Altimmune’s nasal COVID-19 vaccine

  • BioProcess Insider

    Lifecycle approach could cut cell and gene therapy costs

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events